Cascade Investment Fund acquires logistics provider Biocon
Cascade Investment Fund acquires logistics provider Biocon (photo: ifcascade.com)
The Antimonopoly Committee of Ukraine has granted Cascade Investment Fund permission to acquire control over KhFC Biocon, LLC. The decision was approved during the Committee’s meeting on July 3, according to the official website of the regulator.
KhFC Biocon is a full-cycle logistics provider specializing in servicing the pharmaceutical sector. The company focuses on the storage and distribution of products manufactured by international pharmaceutical companies. Currently, Biocon manages approximately 50,000 square meters of Class A and A+ warehouse space designated for the storage and transshipment of medicinal products.
"The acquisition of KhFC Biocon is another step in the strategic development of Cascade Investment Fund’s real estate portfolio. We are gradually expanding our presence in the logistics, commercial, and residential real estate segments, with a focus on projects that offer long-term potential in Ukraine", - said Vitaliy Khomutynnik, CEO of Cascade Investment Fund.
Private company Cascade was established in 1993 by Vitaliy Khomutynnik. Later, the company went through several reorganizations: it was transformed into a private joint-stock company and in 2008 into an investment fund, Cascade.
Nowadays, Cascade Investment Fund is structured as a fund of funds that invests in private equity & venture capital funds as well as hedge funds. Cascade also focuses on real estate and distressed assets around Europe.
